Article
Clinical Neurology
Timo Jan Oberstein, Manuel Alexander Schmidt, Anna Florvaag, Anna-Lena Haas, Eva-Maria Siegmann, Pauline Olm, Janine Utz, Philipp Spitzer, Arnd Doerfler, Piotr Lewczuk, Johannes Kornhuber, Juan Manuel Maler
Summary: In a long-term observational study, it was found that the combination of biomarkers pTau181, A beta 40 and A beta 42 in cerebrospinal fluid (CSF) is not associated with dementia. Individuals with increased levels of CSF-pTau181 without amyloidopathy showed no significant cognitive decline compared to controls.
Article
Clinical Neurology
Anarmaa Mendsaikhan, Ikuo Tooyama, Geidy E. Serrano, Thomas G. Beach, Douglas G. Walker
Summary: This study found decreased levels of PGRN and PSAP proteins in Alzheimer's disease patients and patients with GRN mutations. The results suggest that neuronal loss of PGRN precedes loss of PSAP as tangles develop and mature. Although based on correlative data, reduced levels of PGRN and PSAP and their interaction in neurons might predispose to accumulation of p-Tau protein.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
(2021)
Review
Clinical Neurology
Christina M. Moloney, Val J. Lowe, Melissa E. Murray
Summary: Neurofibrillary tangles, a hallmark of Alzheimer's disease, undergo a dynamic process of maturity that impacts neuron biology and cognitive function. The levels of maturity include pretangles, mature tangles, and ghost tangles, with distinct characteristics observed through tau protein immunostaining and morphologic changes. Post-translational modifications of tau play a significant role in therapeutic targeting strategies for cognitive dysfunction.
ALZHEIMERS & DEMENTIA
(2021)
Article
Clinical Neurology
Vincent Damotte, Sven J. van der Lee, Vincent Chouraki, Benjamin Grenier-Boley, Jeannette Simino, Hieab Adams, Giuseppe Tosto, Charles White, Natalie Terzikhan, Carlos Cruchaga, Maria J. Knol, Shuo Li, Susanna Schraen, Megan L. Grove, Claudia Satizabal, Najaf Amin, Claudine Berr, Steven Younkin, Rebecca F. Gottesman, Luc Buee, Alexa Beiser, David S. Knopman, Andre Uitterlinden, Charles DeCarli, Jan Bressler, Anita DeStefano, Jean-Francois Dartigues, Qiong Yang, Eric Boerwinkle, Christophe Tzourio, Myriam Fornage, M. Arfan Ikram, Philippe Amouyel, Phil de Jager, Christiane Reitz, Thomas H. Mosley, Jean-Charles Lambert, Sudha Seshadri, Cornelia M. van Duijn
Summary: The study identified associations with known major A beta-processing genes, such as APOE and BACE1, which strengthen the relevance of plasma A beta levels as an endophenotype of AD.
ALZHEIMERS & DEMENTIA
(2021)
Article
Clinical Neurology
Emma Nichols, Adam M. M. Brickman, Kaitlin B. B. Casaletto, Kristen Dams-O'Connor, Kristen M. M. George, Raj G. G. Kumar, Priya Palta, Jennifer S. S. Rabin, Claudia L. L. Satizabal, Julie Schneider, Judy Pa, Renaud La Joie
Summary: This study used causal mediation methods to investigate the effects of the APOE genotype on cognitive decline and dementia. The results revealed that the detrimental effect of APOE epsilon 4 on cognition was mediated by both Alzheimer's disease (AD) and non-AD neurodegenerative neuropathologies, while non-AD vascular pathologies did not mediate this effect. Additionally, the protective effect of APOE epsilon 2 on cognition was partly mediated by AD neuropathology and was stronger in women.
ALZHEIMERS & DEMENTIA
(2022)
Article
Neurosciences
Kai Zhou, Peng Wu
Summary: The presence of osteoarthritis interacts with the APOE4 genotype to influence longitudinal change in verbal episodic memory among non-demented older individuals, but not global cognition.
JOURNAL OF ALZHEIMERS DISEASE
(2022)
Review
Neurosciences
Frederique K. Kok, Suzanne L. van Leerdam, Elizabeth C. M. de Lange
Summary: Alzheimer's disease (AD) is the most common form of dementia, but not all individuals with AD pathology develop dementia. Some individuals with AD pathology, known as non-demented individuals with AD neuropathology (NDAN), remain cognitively intact. These individuals are generally higher educated and have a larger cognitive reserve. On a cellular level, they show increased levels of neural stem cells and 'von Economo neurons'. Understanding the mechanisms underlying this resistance to AD pathology could provide insight into normal aging and AD itself. Further research should focus on identifying factors and mechanisms that govern the cognitive resilience in NDAN individuals to find new biomarkers, targets, and better treatments for AD.
JOURNAL OF ALZHEIMERS DISEASE
(2022)
Article
Multidisciplinary Sciences
Xinxing Wu, Chong Peng, Peter T. Nelson, Qiang Cheng
Summary: Alzheimer's disease (AD) and LATE are complex neurodegenerative disorders affecting cognition and behavior. The development of drugs to target these diseases has been slow due to incomplete understanding of associated genes. Analyzing imbalanced data is challenging, but essential for identifying disease-related genes and improving potential treatment strategies.
Article
Biochemistry & Molecular Biology
Yeonsil Moon, Changmok Lim, Yeahoon Kim, Won-Jin Moon
Summary: The study revealed that females may have better BBB integrity in the cingulate and occipital cortices, and sex-related differences in BBB integrity are attenuated with aging or cognitive decline.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Geriatrics & Gerontology
Paula Villela Nunes, Claudia Kimie Suemoto, Roberta Diehl Rodriguez, Renata Elaine Paraizo Leite, Camila Nascimento, Carlos Augusto Pasqualucci, Ricardo Nitrini, Wilson Jacob-Filho, Lea T. Grinberg, Beny Lafer
Summary: This study examined the associations between age-related neuropathological lesions and adult-onset lifetime major depressive disorder (a-MDD), late-life MDD (LLD), or depressive symptoms close to death (DS) in a large community sample of non-demented older adults. The results showed that vascular brain pathology was strongly correlated with depressive symptoms, supporting the vascular hypothesis of depression. Lewy body pathology was found to underlie depressive symptoms close to death. Older adults with DS or LLD should be monitored for possible cognitive decline or neurodegenerative disorders.
NEUROBIOLOGY OF AGING
(2022)
Article
Clinical Neurology
Edmarie Guzman-Velez, Henrik Zetterberg, Joshua T. Fox-Fuller, Clara Vila-Castelar, Justin S. Sanchez, Ana Baena, Gloria Garcia-Ospina, David Aguillon, Enmanuelle Pardilla-Delgado, Jennifer R. Gatchel, Reisa A. Sperling, Keith Johnson, Eric M. Reiman, Kaj Blennow, Francisco Lopera, Yakeel T. Quiroz
Summary: This study found that plasma NfL levels are associated with higher tau burden and worse cognition in PSEN1 E280A mutation carriers. However, they are not related to amyloid beta load. After adjusting for age, elevated plasma NfL levels are only correlated with worse memory recall.
ALZHEIMERS & DEMENTIA
(2021)
Article
Clinical Neurology
Tino Emanuele Poloni, Valentina Medici, Matteo Moretti, Silvia Damiana Visona, Alice Cirrincione, Arenn Faye Carlos, Annalisa Davin, Stella Gagliardi, Orietta Pansarasa, Cristina Cereda, Livio Tronconi, Antonio Guaita, Mauro Ceroni
Summary: The study compared 9 COVID-19 cases and 6 non-COVID controls, finding non-specific changes in COVID-19 patients such as hypoxic-agonal alterations and various degrees of neurodegeneration. COVID-19 brains exhibited increased microglial activation, with a possible boosting of innate immunity and suppression of adaptive immunity. The microglial hyperactivation in the brainstem and hippocampus of COVID-19 patients with delirium appears to be a specific topographical phenomenon, potentially representing the neuropathological basis of COVID-19 encephalopathic syndrome in the elderly.
Article
Clinical Neurology
Alifiya Kapasi, Jennifer Poirier, Ahmad Hedayat, Ashley Scherlek, Srabani Mondal, Tiffany Wu, John Gibbons, Lisa L. Barnes, David A. Bennett, Sue E. Leurgans, Julie A. Schneider
Summary: High-throughput digital pathology provides significant advantages over traditional methods for quantifying Alzheimer's disease pathology, and can overcome challenges associated with traditional microscopy.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
(2023)
Article
Clinical Neurology
Dana Godrich, Eden R. Martin, Gerard Schellenberg, Margaret A. Pericak-Vance, Michael Cuccaro, William K. Scott, Walter Kukull, Thomas Montine, Gary W. Beecham
Summary: This study found that mixed-type pathologies are extremely common in a clinic-based population, with a combination of AD lesions and non-AD lesions being the most prevalent. All types of lesions were associated with clinical outcomes, with most being associated even when controlling for AD pathology. The neuropathological composite score (NPCS) was also found to be associated with clinical outcomes.
ALZHEIMERS & DEMENTIA
(2022)
Article
Geriatrics & Gerontology
Xiwu Wang, Zhaoting Lv, Qian Wu, Huitao Liu, Yanrou Gu, Teng Ye
Summary: Higher levels of total testosterone in plasma were associated with slower decline in brain glucose metabolism in non-demented males, suggesting potential beneficial effects of testosterone on brain function.
FRONTIERS IN AGING NEUROSCIENCE
(2021)
Article
Psychology, Clinical
Mira Leese, Nora Mattek, John P. K. Bernstein, Katherine E. Dorociak, Sarah Gothard, Jeffrey Kaye, Adriana M. Hughes
Summary: This study aimed to develop a brief web-based cognitive assessment tool and establish preliminary norms. The results showed that age was the only demographic variable associated with performance on the assessment tool, with older adults having slower completion time. Male participants generally had longer completion time compared to females. Overall, the tool was well-accepted by participants, with more than half willing to complete it on a weekly basis.
CLINICAL NEUROPSYCHOLOGIST
(2023)
Article
Geriatrics & Gerontology
Jack C. Lennon, Nathan Hantke, Nora Mattek, Chao-Yi Wu, Hiroko Dodge, Rachel Wall, Zachary Beattie, Jeffrey Kaye, Lisa C. Silbert
Summary: A study found that older Veterans and their cohabitants reported significantly higher levels of blue mood and loneliness during the COVID-19 pandemic, as well as a significant decrease in travel away from home. The prevalence of these negative moods was not affected by the rural or urban residence.
CLINICAL GERONTOLOGIST
(2023)
Article
Clinical Neurology
Angelina J. Polsinelli, Ryan J. Wonderlin, Dustin B. Hammers, Alex Pena Garcia, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Laurel Beckett, Sujuan Gao, Sophia Wang, Kala Kirby, Paige E. Logan, Paul Aisen, Jeffrey L. Dage, Tatiana Foroud, Percy Griffin, Leonardo Iaccarino, Joel H. Kramer, Robert Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. Mundada, Melissa E. Murray, Kelly Nudelman, David N. Soleimani-Meigooni, Malia Rumbaugh, Arthur W. Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario F. Mendez, Kyle Womack, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon J. Sha, Raymond S. Turner, Thomas S. Wingo, David A. Wolk, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova
Summary: We investigated NPS and psychotropic medication use in individuals with EOAD using data from LEADS. Affective behaviors were most common in EOAD, while tension and impulse control behaviors were more common in EOnonAD. Psychotropic medication use was higher in EOnonAD. Overall, NPS burden and psychotropic medication use were higher in EOnonAD compared to EOAD participants.
ALZHEIMERS & DEMENTIA
(2023)
Article
Clinical Neurology
Dustin Hammers, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Laurel Beckett, Sujuan Gao, Kala Kirby, Paul L. Aisen, Jeffrey Dage, Tatiana Foroud, Percy T. Griffin, Lea R. Grinberg, Clifford Jack Jr, Joel Kramer, Robert A. Koeppe, Walter Kukull, Nidhi S. Mundada, Renaud N. La Joie, David Soleimani-Meigooni, Leonardo E. Iaccarino, Melissa Murray, Kelly J. Nudelman, Angelina Polsinelli, Malia Rumbaugh, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza S. Atri, Gregory Day, Ranjan R. Duara, Neill S. Graff-Radford, Lawrence T. Honig, David Jones, Joseph F. Masdeu, Mario Mendez, Kyle Womack, Erik U. Musiek, Chiadi Onyike, Meghan Riddle, Emily Rogalski, Steven J. Salloway, Sharon Sha, Raymond Scott S. Turner, Thomas A. Wingo, David C. Wolk, Maria C. Carrillo, Bradford D. Dickerson, Gil G. Rabinovici, Liana Apostolova
Summary: This study provides a comprehensive understanding of early-onset Alzheimer's disease (EOAD) by profiling the baseline characteristics of EOAD patients. The study found that EOAD patients had worse cognitive performance and higher rates of APOE epsilon 4 carrier status. Amnestic presentation was common among EOAD patients, along with other clinical phenotypes.
ALZHEIMERS & DEMENTIA
(2023)
Article
Clinical Neurology
Dustin Hammers, Sara Nemes, Taylor Diedrich, Ani Eloyan, Kala Kirby, Paul Aisen, Joel Kramer, Kelly Nudelman, Tatiana Foroud, Malia Rumbaugh, Alireza S. Atri, Gregory Day, Ranjan R. Duara, Neill S. Graff-Radford, Lawrence T. Honig, David C. Jones, Joseph F. Masdeu, Mario Mendez, Erik U. Musiek, Chiadi Onyike, Meghan Riddle, Emily Rogalski, Steve J. Salloway, Sharon J. Sha, Raymond Scott Turner, Sandra S. Weintraub, Thomas A. Wingo, David Wolk, Bonnie C. Wong, Maria C. Carrillo, Bradford D. Dickerson, Gil G. Rabinovici, Liana Apostolova
Summary: This study investigated the limitations of learning slopes in early-onset dementias and aimed to highlight the sensitivity of learning slopes in discriminating disease severity in cognitively normal participants and those diagnosed with early-onset dementia. The results showed that learning slopes are highly sensitive to early-onset dementias, even when controlling for the effect of total learning and cognitive severity. The rating for the importance of this study is 8 out of 10.
ALZHEIMERS & DEMENTIA
(2023)
Article
Immunology
Max Stevenson, Rency Varghese, Michaeline L. Hebron, Xiaoguang Liu, Nick Ratliff, Amelia Smith, R. Scott Turner, Charbel Moussa
Summary: Treatment with nilotinib in patients with mild-moderate Alzheimer's disease for 12 months can reduce amyloid plaque and cerebrospinal fluid amyloid levels, as well as attenuate hippocampal volume loss. This is achieved by inhibiting DDR-1 gene expression and activity, leading to a reduction in inflammation. Nilotinib may not only clear amyloid and tau but also reduce cerebrovascular fibrosis.
JOURNAL OF NEUROINFLAMMATION
(2023)
Article
Neurosciences
Griffin A. Greco, Mitchell Rock, Matthew Amontree, Maria Fe Lanfranco, Holly Korthas, Sung Hyeok Hong, R. Scott Turner, G. William Rebeck, Katherine Conant
Summary: The APOE4 allele increases the risk for Alzheimer's disease in a dose-dependent manner and is associated with cognitive decline. A study using mice with targeted gene replacement showed that APOE4 reduces neuronal dendritic complexity and impairs learning. APOE4 also reduces gamma oscillation power, important for learning and memory. The present study found that CCL5, an ECM effector, is increased in CSF samples from APOE4 individuals, and TIMPs, which inhibit ECM-degrading enzymes, are increased in APOE4 CSF and brain lysates. Knockout of CCR5, a receptor for CCL5, enhanced gamma power and improved learning and memory.
NEUROBIOLOGY OF DISEASE
(2023)
Article
Clinical Neurology
Jeffrey Dage, Ani Eloyan, Maryanne Thangarajah, Dustin B. Hammers, Anne M. Fagan, Julia D. Gray, Suzanne E. Schindler, Casey Snoddy, Kelly N. H. Nudelman, Kelley M. Faber, Tatiana Foroud, Paul Aisen, Percy T. Griffin, Lea T. Grinberg, Leonardo Iaccarino, Kala Kirby, Joel Kramer, Robert A. Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. Mundada, Melissa E. Murray, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur W. Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza A. Atri, Laurel A. Beckett, Gregory S. Day, Neill R. Graff-Radford, Ranjan S. Duara, Lawrence S. Honig, David T. Jones, Joseph C. Masdeu, Mario F. Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J. Sha, Raymond S. Turner, Thomas S. Wingo, David A. Wolk, Kyle B. Womack, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova
Summary: This study provides a comprehensive analysis of cerebrospinal fluid biomarkers in early-onset Alzheimer's disease (EOAD) and identifies significant differences in biomarker concentrations between different groups. Most biomarkers are found to be correlated with cognition. These findings have important implications for the design of clinical trials for EOAD.
ALZHEIMERS & DEMENTIA
(2023)
Article
Clinical Neurology
Hanna Cho, Nidhi S. Mundada, Liana G. Apostolova, Maria C. Carrillo, Ranjani Shankar, Alinda N. Amuiri, Ehud Zeltzer, Charles C. Windon, David N. Soleimani-Meigooni, Jeremy A. Tanner, Courtney Lawhn Heath, Orit H. Lesman-Segev, Paul Aisen, Ani Eloyan, Hye Sun Lee, Dustin B. Hammers, Kala Kirby, Jeffrey L. Dage, Anne Fagan, Tatiana Foroud, Lea T. Grinberg, Clifford R. Jack, Joel Kramer, Walter A. Kukull, Melissa E. Murray, Kelly Nudelman, Arthur Toga, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily J. Rogalski, Stephen Salloway, Sharon Sha, Raymond Scott Turner, Thomas S. Wingo, David A. Wolk, Robert Koeppe, Leonardo Iaccarino, Bradford C. Dickerson, Renaud La Joie, Gil D. Rabinovici
Summary: This study describes the baseline amyloid-beta and tau-PET results in early-onset Alzheimer's disease. The results show that amyloid-PET can help distinguish early-onset Alzheimer's disease from other cognitive impairments, and tau-PET signal is elevated in a parietal-predominant pattern with higher burden in younger female patients.
ALZHEIMERS & DEMENTIA
(2023)
Article
Clinical Neurology
Sara Nemes, Paige E. Logan, Mohit K. Manchella, Nidhi S. Mundada, Renaud La Joie, Angelina J. Polsinelli, Dustin B. Hammers, Robert A. Koeppe, TatianaM. Foroud, Kelly N. Nudelman, Ani Eloyan, Leonardo Iaccarino, Valerie Dorsant-Ardon, Alexander Taurone, Maryanne Thangarajah, Jeffery L. Dage, Paul Aisen, Lea T. Grinberg, Clifford R. Jack, Joel Kramer, Walter A. Kukull, Melissa E. Murray, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario F. Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J. Sha, Raymond S. Turner, Thomas S. Wingo, Kyle B. Womack, David A. Wolk, Gil D. Rabinovici, Maria C. Carrillo, Bradford C. Dickerson, Liana G. Apostolova
Summary: This study investigated the predictive ability of sex and APOE epsilon 4 carrier status on the pathological burden in early-onset Alzheimer's disease. The results showed that EOAD females had higher amyloid and tau PET burdens compared to males, and EOAD female APOE epsilon 4 non-carriers had higher amyloid PET burdens and greater gray matter atrophy compared to carriers.
ALZHEIMERS & DEMENTIA
(2023)
Article
Clinical Neurology
Justin Bushnell, Dustin B. Hammers, Paul Aisen, Jeffrey L. Dage, Ani Eloyan, Tatiana Foroud, Lea T. Grinberg, Leonardo Iaccarino, Clifford R. Jack Jr, Kala Kirby, Joel Kramer, Robert Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. Mundada, Melissa E. Murray, Kelly Nudelman, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon Sha, Raymond S. Turner, Thomas S. Wingo, David A. Wolk, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova, David G. Clark
Summary: This study assessed the influence of amyloid and diagnostic syndrome on memory scores in early-onset Alzheimer's disease (EOAD) using the Rey Auditory Verbal Learning Test (RAVLT). The results showed that the RAVLT measures were sensitive to the effects of amyloid and syndrome in EOAD.
ALZHEIMERS & DEMENTIA
(2023)
Review
Clinical Neurology
Alexandra Touroutoglou, Yuta Katsumi, Michael Brickhouse, Alexander Zaitsev, Ryan Eckbo, Paul Aisen, Laurel Beckett, Jeffrey L. Dage, Ani Eloyan, Tatiana Foroud, Bernardino Ghetti, Percy Griffin, Dustin Hammers, Clifford R. Jack, Joel H. Kramer, Leonardo Iaccarino, Renaud La Joie, Nidhi S. Mundada, Robert Koeppe, Walter A. Kukull, Melissa E. Murray, Kelly Nudelman, Angelina J. Polsinelli, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph C. Masdeu, Mario F. Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon Sha, R. Scott Turner, Thomas S. Wingo, David A. Wolk, Kyle Womack, Maria C. Carrillo, Gil D. Rabinovici, Liana G. Apostolova, Bradford C. Dickerson, LEADS Consortium
Summary: MRI research has advanced understanding of neurodegeneration in sporadic early-onset Alzheimer's disease, with the EOAD-signature atrophy replicated across different cohorts and associated with the severity of cognitive impairment. This suggests that EOAD-signature atrophy could be a reliable biomarker for AD-related neurodegeneration in clinical trials for EOAD.
ALZHEIMERS & DEMENTIA
(2023)
Review
Clinical Neurology
Ani Eloyan, Maryanne Thangarajah, Na J. An, Bret J. L. Borowski, Ashritha L. Reddy, Paul L. Aisen, Jeffrey L. Dage, Tatiana Foroud, Bernardino Ghetti, Percy Griffin, Dustin Hammers, Leonardo R. Iaccarino, Clifford R. Jack, Kala Kirby, Joel Kramer, Robert A. Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. E. Mundada, Melissa E. Murray, Kelly Nudelman, Malia N. Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Alireza S. Atri, Gregory S. Day, Ranjan R. Duara, Neill R. S. Graff-Radford, Lawrence S. T. Honig, David T. Jones, Joseph F. Masdeu, Mario F. Mendez, Erik U. Musiek, Chiadi U. Onyike, Emily Rogalski, Stephen Salloway, Sharon S. Sha, Raymond S. S. Turner, Thomas S. A. Wingo, David A. Wolk, Kyle Womack, Laurel Beckett, Sujuan C. Gao, Maria C. Carrillo, Gil G. Rabinovici, Liana G. Apostolova, Brad Dickerson, Prashanthi Vemuri, LEADS Consortium
Summary: This study compared white matter hyperintensities (WMHs) in early-onset Alzheimer's disease (EOAD) with cognitively normal (CN) and early-onset amyloid-negative cognitively impaired (EOnonAD) groups. The results showed that EOAD patients had higher WMH volumes compared to CN and EOnonAD patients, and WMH volume was positively correlated with cognitive impairment and tau burden.
ALZHEIMERS & DEMENTIA
(2023)
Review
Clinical Neurology
Kelly N. H. Nudelman, Trever Jackson, Malia Rumbaugh, Ani Eloyan, Marco Abreu, Jeffrey L. Dage, Casey Snoddy, Kelley M. Faber, Tatiana Foroud, Dustin B. Hammers, Alexander Taurone, Maryanne Thangarajah, Paul Aisen, Laurel Beckett, Joel Kramer, Robert Koeppe, Walter A. Kukull, Melissa E. Murray, Arthur W. Toga, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph C. Masdeu, Mario Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J. Sha, R. Scott Turner, Thomas S. Wingo, David A. Wolk, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova
Summary: The Longitudinal Early-onset Alzheimer's Disease Study aims to investigate the genetic causes of early onset cognitive impairment. The study found that the participants had a low frequency of common pathogenic variants.
ALZHEIMERS & DEMENTIA
(2023)
Article
Health Care Sciences & Services
Chao-Yi Wu, Deanne Tibbitts, Zachary Beattie, Hiroko Dodge, Jackilen Shannon, Jeffrey Kaye, Kerri Winters-Stone
Summary: This study found significant differences in health and behavior changes before and after a cancer diagnosis through continuous passive monitoring of older adults. Over the year preceding a cancer diagnosis, there were gradual reductions in step counts and weight, and gradual increases in pain severity, step count variability, hospitalization or emergency room visits, and days away from home overnight. In the year after the cancer diagnosis, there was a gradual increase in the number of pillbox door openings. The results of this study suggest that continuous passive monitoring can provide important information for health management.
JMIR FORMATIVE RESEARCH
(2023)
Article
Geriatrics & Gerontology
Sarah N. Kraeutner, Cristina Rubino, Jennifer K. Ferris, Shie Rinat, Lauren Penko, Larissa Chiu, Brian Greeley, Christina B. Jones, Beverley C. Larssen, Lara A. Boyd
Summary: This study examined the age-related changes in brain function and baseline brain structure that support motor skill acquisition. The findings showed that older adults experienced decreases in functional connectivity during motor skill acquisition, while younger adults experienced increases. Additionally, regardless of age group, lower baseline microstructure in a frontoparietal tract was associated with slower motor skill acquisition.
NEUROBIOLOGY OF AGING
(2024)
Article
Geriatrics & Gerontology
Karen Nuytemans, Farid Rajabli, Melissa Jean-Francois, Jiji Thulaseedhara Kurup, Larry D. Adams, Takiyah D. Starks, Patrice L. Whitehead, Brian W. Kunkle, Allison Caban-Holt, Jonathan L. Haines, Michael L. Cuccaro, Jeffery M. Vance, Goldie S. Byrd, Gary W. Beecham, Christiane Reitz, Margaret A. Pericak-Vance
Summary: This study conducted genetic research on African American AD families and identified a significant linkage signal associated with AD, highlighting the importance of diverse population-level genetic data in understanding the genetic determinants of AD.
NEUROBIOLOGY OF AGING
(2024)
Article
Geriatrics & Gerontology
Kazuya Suwabe, Ryuta Kuwamizu, Kazuki Hyodo, Toru Yoshikawa, Takeshi Otsuki, Asako Zempo-Miyaki, Michael A. Yassa, Hideaki Soya
Summary: Physical exercise has a positive impact on hippocampal memory decline with aging. Recent studies have shown that even light exercise can improve memory and this improvement is mediated by the ascending arousal system. This study aimed to investigate the effects of light-intensity exercise on hippocampal memory function in healthy older adults and found that pupil dilation during exercise played a role in the memory improvement.
NEUROBIOLOGY OF AGING
(2024)
Article
Geriatrics & Gerontology
Ajay Sood, Ana Werneck Capuano, Robert Smith Wilson, Lisa Laverne Barnes, Alifiya Kapasi, David Alan Bennett, Zoe Arvanitakis
Summary: The objective of this study was to explore the impact of metformin on cognition and brain pathology. The results showed that metformin users had slower decline in global cognition, episodic memory, and semantic memory compared to non-users. However, the relationship between metformin use and certain brain pathology remains uncertain.
NEUROBIOLOGY OF AGING
(2024)
Article
Geriatrics & Gerontology
Brian N. Lee, Junwen Wang, Molly A. Hall, Dokyoon Kim, Shana D. Stites, Li Shen
Summary: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory and functional impairments. This study analyzed participants from the Alzheimer's Disease Neuroimaging Initiative and found differential associations between cerebral spinal fluid (CSF)/neuroimaging biomarkers and cognitive/functional outcomes, as well as variations between sexes. These findings suggest that sex differences may play a role in the development of AD.
NEUROBIOLOGY OF AGING
(2024)
Article
Geriatrics & Gerontology
Madeline R. Hale, Rebecca Langhough, Lianlian Du, Bruce P. Hermann, Carol A. Van Hulle, Margherita Carboni, Gwendlyn Kollmorgenj, Kristin E. Basche, Davide Bruno, Leah Sanson-Miles, Erin M. Jonaitis, Nathaniel A. Chin, Ozioma C. Okonkwo, Barbara B. Bendlin, Cynthia M. Carlsson, Henrik Zetterberg, Kaj Blennow, Tobey J. Betthauser, Sterling C. Johnson, Kimberly D. Mueller
Summary: This study demonstrates a relationship between cerebrospinal fluid biomarkers and the ability to recall proper names in the preclinical phase of Alzheimer's disease.
NEUROBIOLOGY OF AGING
(2024)
Article
Geriatrics & Gerontology
Thomas T. Austin, Christian L. Thomas, Ben Warren
Summary: This study investigated the effects of age on the robustness and resilience of auditory system using the desert locust. The researchers found that gene expression changes were mainly influenced by age rather than noise exposure. Both young and aged locusts were able to recover their auditory nerve function within 48 hours of noise exposure, but the recovery of transduction current magnitude was impaired in aged locusts. Key genes responsible for robustness to noise exposure in young locusts and potential candidates for compensatory mechanisms in auditory neurons of aged locusts were identified.
NEUROBIOLOGY OF AGING
(2024)